Scopia Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Indivior Pharmaceuticals
INDV
|
+$220M |
| 2 |
SentinelOne
S
|
+$22.5M |
| 3 |
AerCap
AER
|
+$17.7M |
| 4 |
Qorvo
QRVO
|
+$13M |
| 5 |
Semtech
SMTC
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KBR
KBR
|
+$46.8M |
| 2 |
Harmonic Inc
HLIT
|
+$44.6M |
| 3 |
EnerSys
ENS
|
+$40.9M |
| 4 |
MDU Resources
MDU
|
+$39.1M |
| 5 |
Avery Dennison
AVY
|
+$31.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.73% |
| 2 | Healthcare | 25.79% |
| 3 | Industrials | 24.71% |
| 4 | Consumer Discretionary | 11.64% |
| 5 | Materials | 3.13% |
Similar funds
Scopia Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Scopia Capital Management held 38 positions worth $989M, down 5.9% from $1.05B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Scopia Capital Management withdrew a net $109M in Q2 2023, closing 6 positions and reducing 14 holdings. Its most notable exit was MDU Resources, an estimated $39.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Scopia Capital Management opened a new position in Indivior Pharmaceuticals worth $228M.
- Scopia Capital Management's largest Q2 2023 buy was Indivior Pharmaceuticals: 9,590,921 shares worth $228M.
- Scopia Capital Management added most to Qorvo in Q2 2023, an estimated $13M increase.
- Scopia Capital Management's biggest Q2 2023 reduction was KBR, cutting an estimated $46.8M.
- Scopia Capital Management fully exited MDU Resources in Q2 2023, selling an estimated $39.1M.
- Scopia Capital Management's ten largest holdings make up 66% of its $989M portfolio in Q2 2023.
- Scopia Capital Management opened 6 new positions and closed 6 in Q2 2023.
- Scopia Capital Management's portfolio value fell 5.9% quarter-over-quarter to $989M.
Based on Scopia Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.